Finally, 54.5% (6/11) of patients with B-CLL had a positive TCM CD4+ and CD8+ and humoral responses, while the other patients (5/11) had only a positive TCM response (Figure 4, B-CLL). This evidence concerns the gene CD4 and B-cell chronic lymphocytic leukemia.